Skip to Main Content

Paper Details

Inherited TP53 Variants and Risk of Prostate Cancer.
Eur Urol
37
2022
LFS, Li-Fraumeni syndrome, PATIENT, Prostate Cancer, Prostate cancer, TP53, TP53 Variants, TP53 allele, TP53 gene, attenuated variants, autosomal dominant multicancer, classic LFS, gTP53, gTP53 variants, men, prostate cancer, prostate tumors, tumors
Author NameAffiliation
Heather H ChengUniversity of Washington, USA Fred Hutchinson Cancer Research Center
Brian H ShirtsUniversity of Washington, USA Brotman Baty Institute for Precision Medicine
Eliezer M Van AllenDana-Farber Cancer Institute, Harvard Medical School, The Broad Institute of MIT and Harvard
Eliezer M Van AllenDana-Farber Cancer Institute, Harvard Medical School, The Broad Institute of MIT and Harvard
Wassim AbidaMemorial Sloan Kettering Cancer Center
Bruce MontgomeryUniversity of Washington, USA Fred Hutchinson Cancer Research Center
Michael J MorrisMemorial Sloan Kettering Cancer Center
Robert L NussbaumInvitae Corporation
Judy E GarberDana-Farber Cancer Institute
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonFred Hutchinson Cancer Research Center
Oliver SartorTulane Cancer Center, Tulane Medical School
Michael F WalshMemorial Sloan Kettering Cancer Center
Colin C PritchardUniversity of Washington, USA Brotman Baty Institute for Precision Medicine
  • 1 - 14

Datasets

Release 1.2